Pixl Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.32M

  • Investors
  • 4

Pixl Bio General Information

Description

Operator of an induced pluripotent stem cell biology and artificial intelligence phenomics platform intended to generate reproducible data for drug development. The company's platform offers disease-relevant cell models combined with image-based analysis of cellular morphology, enabling biopharmaceutical researchers to assess drug response, toxicity and mechanism of action.

Contact Information

Website
www.pixl.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Uppsala Science Park
  • 751 83 Uppsala
  • Sweden
+46
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Uppsala Science Park
  • 751 83 Uppsala
  • Sweden
+46

Pixl Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pixl Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 14-Dec-2025 $2.32M Completed Generating Revenue
3. Accelerator/Incubator 13-Nov-2025 Completed Generating Revenue
2. Seed Round 30-Jan-2025 $1.19M $1.19M Completed Generating Revenue
1. Accelerator/Incubator 04-Sep-2024 Completed Startup
To view Pixl Bio’s complete valuation and funding history, request access »

Pixl Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Pixl Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pixl Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an induced pluripotent stem cell biology and artificial intelligence phenomics platform intended to generate
Discovery Tools (Healthcare)
Uppsala, Sweden
21 As of 2026

Cambridge, United Kingdom
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pixl Bio Competitors (6)

One of Pixl Bio’s 6 competitors is bit.bio, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
bit.bio Venture Capital-Backed Cambridge, United Kingdom
Axiom (Biotechnology) Venture Capital-Backed San Francisco, CA
Ncardia Venture Capital-Backed Leiden, Netherlands
Ignota Labs Venture Capital-Backed Cambridge, United Kingdom
Inductive Bio Venture Capital-Backed New York, NY
To view Pixl Bio’s complete competitors history, request access »

Pixl Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pixl Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Uppsala Innovation Centre Accelerator/Incubator
Almi Invest Venture Capital Minority
Nordic Science Investments Venture Capital Minority
STUNS Life Science Accelerator/Incubator
To view Pixl Bio’s complete investors history, request access »

Pixl Bio Acquisitions (1)

Pixl Bio’s most recent deal was a Merger/Acquisition with DefiniGEN. The deal was made on 22-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DefiniGEN 22-Sep-2025 Merger/Acquisition Biotechnology
To view Pixl Bio’s complete acquisitions history, request access »

Pixl Bio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
DefiniGEN Cambridge, United Kingdom 2011

Pixl Bio FAQs

  • When was Pixl Bio founded?

    Pixl Bio was founded in 2021.

  • Where is Pixl Bio headquartered?

    Pixl Bio is headquartered in Uppsala, Sweden.

  • What is the size of Pixl Bio?

    Pixl Bio has 21 total employees.

  • What industry is Pixl Bio in?

    Pixl Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Pixl Bio a private or public company?

    Pixl Bio is a Private company.

  • What is Pixl Bio’s current revenue?

    The current revenue for Pixl Bio is .

  • How much funding has Pixl Bio raised over time?

    Pixl Bio has raised $3.51M.

  • Who are Pixl Bio’s investors?

    Uppsala Innovation Centre, Almi Invest, Nordic Science Investments, and STUNS Life Science have invested in Pixl Bio.

  • Who are Pixl Bio’s competitors?

    bit.bio, Axiom (Biotechnology), Ncardia, Ignota Labs, and Inductive Bio are some of the 6 competitors of Pixl Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process